Infographic: Widespread use of coronavirus antibody tests will still leave many questions

unnamed file
Credit: Tiziana Fabi/AFP

Dozens of antibody tests for the novel coronavirus have become available in recent weeks. And early results from studies of such serological assays in the U.S. and around the world have swept headlines. Despite optimism about these tests possibly becoming the key to a return to normal life, experts say the reality is complicated and depends on how results are used.

[O]verestimates of COVID-19’s spread could lead to underestimates of fatality and hospitalization rates—or excessive confidence about herd immunity. Such immunity is currently thought to require about 70 percent of the population to have been exposed—a rate even hotspots such as New York are likely nowhere near. Any of these errors could, in turn, lead to policies that are bad for public health.

Related article:  Native Australian plant may help develop disease-resistant crops—and a COVID-19 vaccine

Furthermore, overestimating the prevalence of people with SARS-CoV-2 antibodies could create an unwarranted sense of security about the diagnostic role tests can play. Because false positives are more common in places with low disease prevalence, [epidemiologist Tara] Smith notes, “there is the potential for individuals to be misled regarding their [antibody] status. If they are false positive, they may believe they are immune when they are not and may relax protective measures.”

Credit: Amanda Montañez

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend